¸Þµð¾÷

´ëÇк´¿ø Çѹ溴¿ø
Á¾ÇÕº´¿ø ³ëÀκ´¿ø
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹Á¤º¸
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ëºÐ¾ç¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
¸ÞµðÅå
´ëÇк´¿ø Á¾ÇÕº´¿ø Çѹ溴¿ø Ä¡°úº´¿ø ÇÑÀÇ¿ø ³ëÀÎÀü¹®º´¿ø º¸°Ç¼Ò
¼­¿ï ºÎ»ê ÀÎõ ´ë±¸ ´ëÀü ±¤ÁÖ ¿ï»ê °æ±â °­¿ø ÃæºÏ Ãæ³² °æºÏ °æ³² ÀüºÏ Àü³² Á¦ÁÖ ¼¼Á¾
Ä¡°ú ¾È°ú ÇǺΰú ¼ºÇü¿Ü°ú »êºÎÀΰú ºñ´¢±â°ú ¿Ü°ú ³»°ú Á¤Çü¿Ü°ú À̺ñÀÎÈÄ°ú ¼Ò¾Æ°ú ¾à±¹

¸ñ·Ï ¼öÁ¤ »èÁ¦

2023³âµµ ´ëÇѺñ´¢ÀÇÇÐȸ ÅëÇÕÇмú´ëȸ(KUCE 2023) (1ÀÏÂ÷) : 2023-04-14

ÃßõÇϱâ
¿¬¼ö°­Á À̹øÁÖ BEST
 

2023³âµµ ´ëÇѺñ´¢ÀÇÇÐȸ ÅëÇÕÇмú´ëȸ(KUCE 2023) (1ÀÏÂ÷) : 2023-04-14
±³À°ÀÏÀÚ : 2023-04-14
±³À°Àå¼Ò : DCC Á¦2ȸÀÇÀå

±³À°ÁÖÁ¦ : 2023³âµµ ´ëÇѺñ´¢ÀÇÇÐȸ ÅëÇÕÇмú´ëȸ(KUCE 2023) (1ÀÏÂ÷)

ÁÖÃÖ±â°ü : ´ëÇѺñ´¢ÀÇÇÐȸ(19.2 ¸íĪº¯°æ ´ëÇѺñ´¢±â°úÇÐȸ)
´ã´çÀÚ : À̼¼Èñ
¿¬¶ôó : 02-573-8190  

À̸ÞÀÏ : urology@urology.or.kr

±³À°Á¾·ù : ºñ´¢ÀÇÇаú

Âü¼®¿¹»óÀοø : 500¸í
Èñ¸ÁÆòÁ¡ : 4Á¡

Áö¿ª : ´ëÀü±¤¿ª½Ã
±³À°½Ã°£ : 4 ½Ã°£ 0ºÐ

¼¼ºÎ¼ö°­·á : 110,000¿ø  

ºñ°í »çÀüµî·Ï Á¤È¸¿ø: 88,000¿ø ±ºÀÇ°ü/°øº¸ÀÇ: 44,000¿ø Àü°øÀÇ: 33,000¿ø ±¹Á¦È¸¿ø: 88,000¿ø °£È£»ç/¿¬±¸¿ø: 38,500¿ø Á¦¾àȸ»ç ¹× ÀÇ·á±âȸ»ç Á÷¿ø/±âŸ: 110,000¿ø


±¸ºÐ ¿ùÀÏ °­ÀÇ½Ç ½Ã°£ ±³À°Á¦¸ñ °­»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ

±³À°½Ã°£ 04-14 Á¦2ȸÀÇÀå(103+104) 13:00~13:20 ÃֽŠÀÇ·áÀΰøÁö´É ¿¬±¸µ¿Çâ ¹× ÀÓ»óÀÇÀÇ ¿ªÇÒ Á¤¼º¹®(°æºÏÀÇ´ë ÀÇ·áÁ¤º¸Çб³½Ç)

±³À°½Ã°£ 04-14 Á¦2ȸÀÇÀå(103+104) 13:20~13:40 ÀÇ·áÀΰøÁö´É ¿¬±¸¸¦ À§ÇÑ Áغñ ¹× ÀýÂ÷ Ã߹μö(¼­¿ïÀÇ´ë)

±³À°½Ã°£ 04-14 Á¦2ȸÀÇÀå(103+104) 13:40~14:00 ÀǷ῵»ó ±â¹ÝÀÇ ÀΰøÁö´É ¿¬±¸ ±è¿µ°ï(¼­¿ïÀÇ´ë À¶ÇÕÀÇÇаú)

±³À°½Ã°£ 04-14 Á¦2ȸÀÇÀå(103+104) 14:00~14:20 ºñ´¢±â ¿µ¿ª¿¡¼­ ÀΰøÁö´ÉÀÇ Àû¿ë»ç·Ê ±èÀÀÈñ(¶óÀÌÇÁ½Ã¸Çƽ½º)

±³À°½Ã°£ 04-14 Á¦2ȸÀÇÀå(103+104) 14:30~14:50 The role of I-O agents in non-metastatic urothelial carcinoma ÀÓ¹üÁø(¿ï»êÀÇ´ë)

±³À°½Ã°£ 04-14 Á¦2ȸÀÇÀå(103+104) 14:50~15:10 Peri-operative immunotherapy in high-risk, non-metastatic RCC Á¶Á¤±â(ÇѾçÀÇ´ë)

±³À°½Ã°£ 04-14 Á¦2ȸÀÇÀå(103+104) 15:10~15:30 Management of I-O drug related complications in urologic cancer: sharing basic knowledge ÇÔ¿ø½Ä(¿¬¼¼ÀÇ´ë)

±³À°½Ã°£ 04-14 Á¦2ȸÀÇÀå(103+104) 15:30~15:50 Management of I-O drug related complications in urologic cancer: sharing real clinical practice ±èÁÂÈÆ(°í·ÁÀÇ´ë Á¾¾ç³»°ú)

±³À°½Ã°£ 04-14 Á¦2ȸÀÇÀå(103+104) 16:10~16:30 Management of low testosterone in prostate cancer survivors ½ÅÀ¯¼·(ÀüºÏÀÇ´ë)

±³À°½Ã°£ 04-14 Á¦2ȸÀÇÀå(103+104) 16:30~16:50 Effects of COVID-19 on male sexual health ¾È¼øÅÂ(°í·ÁÀÇ´ë)

±³À°½Ã°£ 04-14 Á¦2ȸÀÇÀå(103+104) 16:50~17:10 Does Low intensity shockwave therapy have a role for urological diseases other than ED? ±è°­¼·(°¡Å縯ÀÇ´ë)

±³À°½Ã°£ 04-14 Á¦2ȸÀÇÀå(103+104) 17:10~17:30 Office-based management of premature ejaculation ÃÖ¿ì¼®(°Ç±¹ÀÇ´ë)

 

ÆÄ¿ö¸µÅ© ±¤°íµî·Ï
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
¸Þµð¾÷
" 2023³âµµ ´ëÇѺñ´¢ÀÇÇÐȸ ÅëÇÕÇмú´ëȸ(KUCE 2023) (1ÀÏÂ÷) : 2023-04-14""ÀÇ ÀÌ¿ëÈı⳪ Ãßõ´ñ±ÛÀ» ³²°Ü À¯¿ëÇÑ Á¤º¸·Î °øÀ¯ÇսôÙ. ^^
¡å
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
 
¸ñ·Ï ¼öÁ¤ »èÁ¦
ÀÌÀü±Û Á¦73Â÷ ´ëÇѼҾÆû¼Ò³â°úÇÐȸ Ãá°èÇмú´ëȸ : 2023-04-14
´ÙÀ½±Û 2023 ´ëÇÑÇ×±Õ¿ä¹ýÇÐȸ ´ëÇÑ°¨¿°ÇÐȸ Ãá°è Çмú´ëȸ : 2023-04-13
¹øÈ£ Á¦¸ñ Ãßõ Á¶È¸ µî·ÏÀÏ
77 ±¤ÁÖ Á¦30Â÷ ´ëÇÑ·ù¸¶Æ¼½ºÇÐȸ ¿¬¼ö°­Á : 2018-08-19 0 781 2018-07-28
76 ¼­¿ï »ï¼º¼­¿ïº´¿ø Á¦ 3ȸ Current Concepts and Techniques In Knee Surgery (CCTIKS) -SMC Live Surgery & Symposium- : 2018-08-19 0 692 2018-07-28
75 ¼­¿ï 2018 °í·Á´ëÇб³ ÀÇ°ú´ëÇÐ »êºÎÀΰú ¿¬¼ö°­Á : 2018-08-19 0 858 2018-07-28
74 ºÎ»ê 2018³â ´ëÇѼÒÈ­±â¿¬°üÇÐȸ ºÎ¿ï°æÁöȸ ¿¬¼ö°­Á : 2018-08-19 0 928 2018-07-28
73 ´ë±¸ ´ëÇѳ»°úÇÐȸ Á¦18ȸ ³»°úÀü¹®ÀÇ Æò»ý±³À° ¿¬¼ö°­Á : 2018-08-19 0 535 2018-07-28
72 ¼­¿ï ´ëÇѼҾÆû¼Ò³âÁ¤½ÅÀÇÇÐȸ 2018³âµµ ¼ºÀÎADHD¿¬±¸È¸ "¼ºÀÎ ADHD Áø·áÀÇ ½ÇÀü ±æ¶óÀâÀÌ" : 2018-08-19 0 880 2018-07-28
71 ¼­¿ï Á¦3ȸ ´ëÇѼҾÆû¼Ò³â°úÀÇ»çȸ ÃÊÀ½ÆÄ¿öÅ©¼¥ : 2018-08-19 0 640 2018-07-28
70 ¼­¿ï ´ëÇѺñ°úÇÐȸ RHINOLOGY UPDATE SYMPOSIUM IN 2018 : 2018-08-18 0 496 2018-07-28
69 ´ë±¸ 2018³âµµ ´ëÇѽŰæ¿Ü°úÇÐȸ ´ë±¸¡¤°æºÏÁöȸ Á¦3Â÷ ¿¬¼ö±³À° : 2018-08-18 0 486 2018-07-28
68 °æ±â 2018 °í·Á´ëÇб³¾È»êº´¿ø °¡Á¤ÀÇÇаú °³¿øÀÇ ¿¬¼ö°­Á : 2018-08-18 0 729 2018-07-28
67 ¼­¿ï ¼­¿ï´ëÇб³º´¿ø Highlighted Access on Disease Recurrence Of Cervical cancer(HADROC) Symposium : 2018-08-18 0 652 2018-07-28
66 ¼­¿ï 2018 ´ëÇѽÉÆóÇ÷°ü¸¶ÃëÇÐȸ ¿¬¼ö°­Á : 2018-08-18 0 607 2018-07-28
65 ¼­¿ï 2018 ´ëÇѽÉÆóÇ÷°ü¸¶ÃëÇÐȸ TEE Workshop : 2018-08-18 0 757 2018-07-28
64 ºÎ»ê ´ëÇѽɺÎÀüÇÐȸ ÇÏ°è ½ÉÆ÷Áö¾ö : 2018-08-18 0 617 2018-07-28
63 °æ±â ÇѸ²´ëÇб³¼º½Éº´¿ø Á¦7ȸ Áö¿ª»çȸº´¿ø°ú ÇÔ²²ÇÏ´Â °¨¿°°ü¸® ½ÉÆ÷Áö¿ò : 2018-08-18 0 889 2018-07-28
1401 | 1402 | 1403 | 1404 | 1405 | 1406 | 1407 | 1408 | 1409 | 1410
 
Ä¿¹Â´ÏƼ
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ë¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
º´¿øȨÆäÀÌÁö
¸ÞµðÅå
ÇÑÀÇ¿ø
¼ºÇü¿Ü°ú
Ä¡°ú
¾È°ú
¿©¼ºº´¿ø
³»°ú
Á¤Çü¿Ü°ú
ÇǺΰú
¼Ò¾Æ°ú
À̺ñÀÎÈÄ°ú
ºñ´¢ÀÇÇаú
¿ä¾çº´¿ø
ÀçÈ°ÀÇÇаú
µ¿¹°º´¿ø
±âŸº´ÀÇ¿ø
Ãë¾÷°ü·Ã
Áö¿ø¼­¾ç½Ä
¼­·ù¾ç½Ä
¸Þµð¾÷ ¸ð¹ÙÀÏÀ¥
¸Þµð¾÷